Associate Professor, Department of Medicine
University of California, USA
Dr. Weibin Shi received his medical training in China and PhD in pathology from McGill University in Canada. His postdoctoral fellowship was carried out in the Department of Medicine at University of California, Los Angeles. Dr. Shi joined the University of Virginia School of Medicine as an Assistant Professor in 2001, and he was promoted to Associate Professor in 2005. The general research program of his laboratory has been focused on the cellular and genetic aspects of atherosclerosis. His group has identified a dozen of quantitative trait loci (QTL), including Ath22, CAth1, Bglu3, Nih1, sVcam1, and sSelp1 that influence atherosclerotic lesions, neointimal hyperplasia, plasma lipid and glucose levels, soluble adhesion molecules or body weight. He has published over 50 peer reviewed articles and been first or senior authored on nearly 40. Dr. Shi has served as a grant reviewer for the National Institutes of Health, Juvenile Diabetes Research Foundation, and American Heart Association-Mid-Atlantic Affiliate. He has been an ad hoc reviewer for numerous prestigious journals.
Cellular and Genetic aspects of Atherosclerosis